Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.7683 USD | -1.15% | -0.05% | +4.53% |
2023 | NGM Biopharmaceuticals Says Phase 2b Trial of Potential Cirrhosis Treatment Meets Primary Endpoint | MT |
2023 | Alpine 4 Holdings, Inc.(NasdaqCM:ALPP) dropped from S&P Global BMI Index | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationQuarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+4.53% | 21M | |
+13.46% | 109B | |
+0.17% | 29.83B | |
+12.56% | 22.54B | |
-12.03% | 18.58B | |
-7.41% | 17.14B | |
+15.79% | 16.45B | |
-5.75% | 12.03B | |
+0.88% | 10.97B | |
-13.87% | 8.91B |
- Stock Market
- Equities
- ALPP Stock
- News Alpine 4 Holdings, Inc.
- Alpine 4 Says Nasdaq Grants Extension to Comply With Minimum Bid Price Rule; Shares Rise